News from March 2024

A global scientific consortium which set out to control two major livestock virus epidemics in Europe is celebrating five years of research findings. Coordinated and led by The Pirbright Institute, and funded through the European Union’s Horizon 2020 innovation and research programme, DEFEND brought…

In an effort to combat the devastating impact of African swine fever (ASF) on global food security, Pirbright researchers have secured funding from the Medical Research Council to assess the cross-protection potential of modified live vaccines (MLV) against diverse ASF virus (ASFV) strains in Africa…

Vector-borne viruses pose a significant global health threat, particularly in low- and middle-income tropical countries. Pirbright researchers and their collaborators from the London School of Hygiene and Tropical Medicine have secured a grant from the Medical Research Council to develop innovative…

A new collaboration between the The Pirbright Institute and the UK Health Security Agency (UKHSA) has been initiated to support the development of vaccines against a group of lethal viruses. Researchers will address the threat of outbreaks caused by previously unknown or emerging henipaviruses, akin…